Advertisement
Advertisement
ALC
Alcon Inc. Ordinary Shares
70.21
USDSponsored
+1.27
+1.84%
Aug 03, 15:59 UTC -4
Closed
Pre-Market
70.06
-0.15
-0.22%
ALC Earnings Reports
Positive Surprise Ratio
ALC beat 20 of 29 last estimates.
69%
Next Report
Next Week
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.80B
/$0.76
Implied change from Q1 26 (Revenue/ EPS)
+4.16%
/-10.59%
Implied change from Q2 25 (Revenue/ EPS)
+8.53%
/--
Alcon Inc. Ordinary Shares earnings per share and revenue
On May 05, 2026, ALC reported earnings of 0.85 USD per share (EPS) for Q1 26, beating the estimate of 0.82 USD, resulting in a 3.41% surprise. Revenue reached 2.69 billion, compared to an expected 2.74 billion, with a -1.99% difference. The market reacted with a -12.14% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.76 USD, with revenue projected to reach 2.80 billion USD, implying an decrease of -10.59% EPS, and increase of 4.16% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DexCom, Inc.
Report Date
Jul 30, 2026 For Q1 26
Estimate
$0.62
Actual
$0.70
Surprise
+12.38%
DexCom, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.68
Actual
$0.70
Surprise
+1.92%
Penumbra, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.08
Actual
$0.88
Surprise
-18.96%
Veracyte, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.24
Actual
$0.31
Surprise
+28.15%
Axogen, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.12
Actual
$0.12
Surprise
-3.15%
iRadimed Corporation
Report Date
Jul 31, 2026 For Q2 26
Estimate
$0.42
Actual
$0.46
Surprise
+7.38%
Integra LifeSciences Holdings
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.49
Actual
$0.56
Surprise
+13.57%
SI-BONE, Inc. Common Stock
Report Date
Aug 03, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.09
Surprise
+41.02%
Beta Bionics, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.53
Surprise
+12.77%
ClearPoint Neuro, Inc. Common Stock
Report Date
Aug 03, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.38
Surprise
-29.96%
FAQ
What were Alcon Inc. Ordinary Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Alcon Inc. Ordinary Shares reported EPS of $0.85, beating estimates by 3.41%, and revenue of $2.69B, -1.99% below expectations.
How did the market react to Alcon Inc. Ordinary Shares's Q1 2026 earnings?
The stock price moved down -12.14%, changed from $74.45 before the earnings release to $65.41 the day after.
When is Alcon Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Alcon Inc. Ordinary Shares's next earnings report?
Based on --
analysts, Alcon Inc. Ordinary Shares is expected to report EPS of $0.76 and revenue of $2.80B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement